Literature DB >> 25795792

Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses.

Zeynep Akgoc1, Miguel Sena-Esteves2, Douglas R Martin3, Xianlin Han4, Alessandra d'Azzo5, Thomas N Seyfried1.   

Abstract

Bis(monoacylglycero)phosphate (BMP) is a negatively charged glycerophospholipid with an unusual sn-1;sn-1' structural configuration. BMP is primarily enriched in endosomal/lysosomal membranes. BMP is thought to play a role in glycosphingolipid degradation and cholesterol transport. Elevated BMP levels have been found in many lysosomal storage diseases (LSDs), suggesting an association with lysosomal storage material. The gangliosidoses are a group of neurodegenerative LSDs involving the accumulation of either GM1 or GM2 gangliosides resulting from inherited deficiencies in β-galactosidase or β-hexosaminidase, respectively. Little information is available on BMP levels in gangliosidosis brain tissue. Our results showed that the content of BMP in brain was significantly greater in humans and in animals (mice, cats, American black bears) with either GM1 or GM2 ganglioside storage diseases, than in brains of normal subjects. The storage of BMP and ganglioside GM2 in brain were reduced similarly following adeno-associated viral-mediated gene therapy in Sandhoff disease mice. We also found that C22:6, C18:0, and C18:1 were the predominant BMP fatty acid species in gangliosidosis brains. The results show that BMP accumulates as a secondary storage material in the brain of a broad range of mammals with gangliosidoses.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  GM1-gangliosidosis; Sandhoff disease; brain lipids; fatty acid; gangliosides; gene therapy; lysosomal; phospholipids; storage diseases

Mesh:

Substances:

Year:  2015        PMID: 25795792      PMCID: PMC4409277          DOI: 10.1194/jlr.M057851

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  78 in total

Review 1.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

2.  Differential cellular enrichment of gangliosides in the mouse cerebellum: analysis using neurological mutants.

Authors:  T N Seyfried; R K Yu; N Miyazawa
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

3.  Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase.

Authors:  C N Hahn; M del Pilar Martin; M Schröder; M T Vanier; Y Hara; K Suzuki; K Suzuki; A d'Azzo
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

4.  Regulation of the NPC2 protein-mediated cholesterol trafficking by membrane lipids.

Authors:  Hichem D Gallala; Bernadette Breiden; Konrad Sandhoff
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

5.  GM1-gangliosidosis in American black bears: clinical, pathological, biochemical and molecular genetic characterization.

Authors:  Sureshkumar Muthupalani; Paola A Torres; Betty C Wang; Bai Jin Zeng; Samuel Eaton; Ildiko Erdelyi; Rebecca Ducore; Rajanikarath Maganti; John Keating; Bain J Perry; Florina S Tseng; Nicole Waliszewski; Mark Pokras; Robert Causey; Rita Seger; Philip March; Amy Tidwell; Rolf Pfannl; Thomas Seyfried; Edwin H Kolodny; Joseph Alroy
Journal:  Mol Genet Metab       Date:  2014-02-13       Impact factor: 4.797

6.  Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles.

Authors:  R J Mason; T P Stossel; M Vaughan
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

7.  Metabolism of bis(monoacylglycero)phosphate in macrophages.

Authors:  S Huterer; J Wherrett
Journal:  J Lipid Res       Date:  1979-11       Impact factor: 5.922

8.  Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.

Authors:  D Phaneuf; N Wakamatsu; J Q Huang; A Borowski; A C Peterson; S R Fortunato; G Ritter; S A Igdoura; C R Morales; G Benoit; B R Akerman; D Leclerc; N Hanai; J D Marth; J M Trasler; R A Gravel
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

Review 9.  Secondary lipid accumulation in lysosomal disease.

Authors:  Steven U Walkley; Marie T Vanier
Journal:  Biochim Biophys Acta       Date:  2008-12-09

10.  Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats.

Authors:  Gulnahar B Mortuza; William A Neville; Jane Delaney; Catherine J Waterfield; Patrick Camilleri
Journal:  Biochim Biophys Acta       Date:  2003-03-17
View more
  21 in total

1.  Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity.

Authors:  Susi Anheuser; Bernadette Breiden; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2015-07-14       Impact factor: 5.922

Review 2.  Strategies to Improve/Eliminate the Limitations in Shotgun Lipidomics.

Authors:  Changfeng Hu; Qiao Duan; Xianlin Han
Journal:  Proteomics       Date:  2019-08-08       Impact factor: 3.984

3.  Novel strategies for enhancing shotgun lipidomics for comprehensive analysis of cellular lipidomes.

Authors:  Changfeng Hu; Chunyan Wang; Lijiao He; Xianlin Han
Journal:  Trends Analyt Chem       Date:  2018-11-27       Impact factor: 12.296

4.  Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.

Authors:  Keisuke Kitakaze; Yasumichi Mizutani; Eiji Sugiyama; Chikako Tasaki; Daisuke Tsuji; Nobuo Maita; Takatsugu Hirokawa; Daisuke Asanuma; Mako Kamiya; Kohei Sato; Mitsutoshi Setou; Yasuteru Urano; Tadayasu Togawa; Akira Otaka; Hitoshi Sakuraba; Kohji Itoh
Journal:  J Clin Invest       Date:  2016-03-28       Impact factor: 14.808

5.  Bis(monoacylglycero)phosphate as a Macrophage Enriched Phospholipid.

Authors:  Zeynep Akgoc; Sonia Iosim; Thomas N Seyfried
Journal:  Lipids       Date:  2015-07-24       Impact factor: 1.880

6.  Bis(monoacylglycero)phosphate lipids in the retinal pigment epithelium implicate lysosomal/endosomal dysfunction in a model of Stargardt disease and human retinas.

Authors:  David M G Anderson; Zsolt Ablonczy; Yiannis Koutalos; Anne M Hanneken; Jeffrey M Spraggins; M Wade Calcutt; Rosalie K Crouch; Richard M Caprioli; Kevin L Schey
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

7.  Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans.

Authors:  Gernot F Grabner; Nermeen Fawzy; Maria A Pribasnig; Markus Trieb; Ulrike Taschler; Michael Holzer; Martina Schweiger; Heimo Wolinski; Dagmar Kolb; Angela Horvath; Rolf Breinbauer; Thomas Rülicke; Roland Rabl; Achim Lass; Vanessa Stadlbauer; Birgit Hutter-Paier; Rudolf E Stauber; Peter Fickert; Rudolf Zechner; Gunther Marsche; Thomas O Eichmann; Robert Zimmermann
Journal:  J Lipid Res       Date:  2019-03-20       Impact factor: 5.922

8.  First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro.

Authors:  Alberto Canfrán-Duque; Luis C Barrio; Milagros Lerma; Gema de la Peña; Jorge Serna; Oscar Pastor; Miguel A Lasunción; Rebeca Busto
Journal:  Int J Mol Sci       Date:  2016-03-18       Impact factor: 5.923

9.  Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease.

Authors:  T N Seyfried; H Choi; A Chevalier; D Hogan; Z Akgoc; J S Schneider
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

10.  Intracellular cholesterol trafficking is dependent upon NPC2 interaction with lysobisphosphatidic acid.

Authors:  Leslie A McCauliff; Annette Langan; Ran Li; Olga Ilnytska; Debosreeta Bose; Miriam Waghalter; Kimberly Lai; Peter C Kahn; Judith Storch
Journal:  Elife       Date:  2019-10-03       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.